Literature DB >> 24077685

Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study.

Lori Wiener, Kristin Baird, Caroline Crum, Kimberly Powers, Paul Carpenter, K Scott Baker, Margaret L MacMillan, Eneida Nemecek, Jin-Shei Lai, Sandra A Mitchell, David A Jacobsohn.   

Abstract

PURPOSE: Chronic graft-versus-host disease (cGVHD) is a significant cause of mortality and morbidity after allogeneic hematopoietic cell transplant and is associated with a wide range of distressing symptoms. A pediatric measure of cGVHD-related symptoms is needed to advance clinical research. Our aim was to elicit descriptions of the cGVHD symptom experience directly from children and to compare the specific language used by children to describe their symptoms and the comprehension of symptom concepts across the developmental spectrum.
METHODS: We used qualitative methods to identify the phrases, terms, and constructs that children (ages 5–8 [n =8], 9–12 [n =8], and 13–17 [n =8]) with cGVHD employ when describing their symptoms. The symptom experience of each participant was determined through individual interviews with each participant and parent (5–7 year olds were interviewed together with a parent). Medical practitioners with experience in evaluating cGVHD performed clinical assessments of each participant.
RESULTS: Pediatric transplant survivors and their parents identified a wide range of bothersome cGVHD symptoms, and common concepts and terminologies to describe these experiences emerged. Overall concordance between patient and parent reports was moderate (70–75 %). No consistent pattern of child under- or over-reporting in comparison to the parent report was observed.
CONCLUSION: These study results identify concepts and vocabulary to inform item generation for a new pediatric self-report measure of cGVHD symptoms for use in clinical research. The findings also confirm the prevalence and nature of symptom distress in pediatric patients with cGVHD and support implementation of systematic approaches to symptom assessment and intervention in routine clinical practice.

Entities:  

Mesh:

Year:  2014        PMID: 24077685      PMCID: PMC5176341          DOI: 10.1007/s00520-013-1957-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  28 in total

1.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-13       Impact factor: 5.725

2.  Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

Authors:  David A Jacobsohn; Brenda F Kurland; Joseph Pidala; Yoshihiro Inamoto; Xiaoyu Chai; Jeanne M Palmer; Sally Arai; Mukta Arora; Madan Jagasia; Corey Cutler; Daniel Weisdorf; Paul J Martin; Steven Z Pavletic; Georgia Vogelsang; Stephanie J Lee; Mary E D Flowers
Journal:  Blood       Date:  2012-07-06       Impact factor: 22.113

3.  Maternal perspectives on children's health-related quality of life during the first year after pediatric hematopoietic stem cell transplant.

Authors:  Susan K Parsons; Mei-Chiung Shih; Katherine N Duhamel; Jamie Ostroff; Deborah K Mayer; Jane Austin; D Richard Martini; Sharon E Williams; Laura Mee; Sandra Sexson; Sherrie H Kaplan; William H Redd; Sharon Manne
Journal:  J Pediatr Psychol       Date:  2005-09-08

Review 4.  Characteristics of health-related self-report measures for children aged three to eight years: a review of the literature.

Authors:  Joanne Cremeens; Christine Eiser; Mark Blades
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

5.  Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

Authors:  Steven Z Pavletic; Paul Martin; Stephanie J Lee; Sandra Mitchell; David Jacobsohn; Edward W Cowen; Maria L Turner; Gorgun Akpek; Andrew Gilman; George McDonald; Mark Schubert; Ann Berger; Peter Bross; Jason W Chien; Daniel Couriel; J P Dunn; Jane Fall-Dickson; Ann Farrell; Mary E D Flowers; Hildegard Greinix; Steven Hirschfeld; Lynn Gerber; Stella Kim; Robert Knobler; Peter A Lachenbruch; Frederick W Miller; Barbara Mittleman; Esperanza Papadopoulos; Susan K Parsons; Donna Przepiorka; Michael Robinson; Michael Ward; Bryce Reeve; Lisa G Rider; Howard Shulman; Kirk R Schultz; Daniel Weisdorf; Georgia B Vogelsang
Journal:  Biol Blood Marrow Transplant       Date:  2006-03       Impact factor: 5.742

6.  Clinical benefit of response in chronic graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Paul J Martin; Xiaoyu Chai; Madan Jagasia; Jeanne Palmer; Joseph Pidala; Corey Cutler; Steven Z Pavletic; Mukta Arora; David Jacobsohn; Paul A Carpenter; Mary E D Flowers; Nandita Khera; Georgia B Vogelsang; Daniel Weisdorf; Barry E Storer; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-06       Impact factor: 5.742

Review 7.  Comparison between patient-reported and clinician-observed symptoms in oncology.

Authors:  Canhua Xiao; Rosemary Polomano; Deborah Watkins Bruner
Journal:  Cancer Nurs       Date:  2013 Nov-Dec       Impact factor: 2.592

8.  The Minneapolis-Manchester Quality of Life instrument: Reliability and validity of the Youth Form.

Authors:  Smita Bhatia; Meriel E M Jenney; Eric Wu; Monica K Bogue; Todd H Rockwood; James H Feusner; Debra L Friedman; Leslie L Robison; Robert L Kane
Journal:  J Pediatr       Date:  2004-07       Impact factor: 4.406

9.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Authors:  H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

10.  The PedsQL Family Impact Module: preliminary reliability and validity.

Authors:  James W Varni; Sandra A Sherman; Tasha M Burwinkle; Paige E Dickinson; Pamela Dixon
Journal:  Health Qual Life Outcomes       Date:  2004-09-27       Impact factor: 3.186

View more
  5 in total

1.  NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD.

Authors:  L M Curtis; L Grkovic; S A Mitchell; S M Steinberg; E W Cowen; M B Datiles; J Mays; C Bassim; G Joe; L E Comis; A Berger; D Avila; T Taylor; D Pulanic; K Cole; J Baruffaldi; D H Fowler; R E Gress; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2014-08-25       Impact factor: 5.483

2.  Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.

Authors:  Stephanie J Lee; Daniel Wolff; Carrie Kitko; John Koreth; Yoshihiro Inamoto; Madan Jagasia; Joseph Pidala; Attilio Olivieri; Paul J Martin; Donna Przepiorka; Iskra Pusic; Fiona Dignan; Sandra A Mitchell; Anita Lawitschka; David Jacobsohn; Anne M Hall; Mary E D Flowers; Kirk R Schultz; Georgia Vogelsang; Steven Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-19       Impact factor: 5.742

Review 3.  Patient and Caregiver Adjustment to Hematopoietic Stem Cell Transplantation: a Systematic Review of Dyad-Based Studies.

Authors:  Shelby Langer; Christine Lehane; Jean Yi
Journal:  Curr Hematol Malig Rep       Date:  2017-08       Impact factor: 3.952

4.  Health-related quality of life in pediatric patients after allogeneic SCT: development of the PedsQL Stem Cell Transplant module and results of a pilot study.

Authors:  A Lawitschka; E D Güclü; J W Varni; M Putz; D Wolff; S Pavletic; H Greinix; C Peters; R Felder-Puig
Journal:  Bone Marrow Transplant       Date:  2014-05-12       Impact factor: 5.483

5.  EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

Authors:  Helene M Schoemans; Stephanie J Lee; James L Ferrara; Daniel Wolff; John E Levine; Kirk R Schultz; Bronwen E Shaw; Mary E Flowers; Tapani Ruutu; Hildegard Greinix; Ernst Holler; Grzegorz Basak; Rafael F Duarte; Steven Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2018-06-05       Impact factor: 5.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.